What should the D9612 chart note include?
Pick your PMS to format the placeholders, then copy.
Therapeutic drug - two or more administrations. RMH: Medical history reviewed/updates Allergies verified. Weight: Weight Indication: Indication/diagnosis Related procedure: Related procedure Administration 1: Administration 1 Time: Time Drug name: Drug name Dose: Dose Route: Route Site: Site/tooth area Lot #: Lot # Exp: Exp Administration 2: Administration 2 Time: Time Drug name: Drug name Dose: Dose Route: Route Site: Site/tooth area Lot #: Lot # Exp: Exp Administration 3 (if applicable): Administration 3 if applicable Time: Time Drug name: Drug name Dose: Dose Route: Route Site: Site/tooth area Vital Signs Monitoring: Pre-administration vitals: BP/HR Post-administration vitals: BP/HR Patient Response: Patient response Adverse reaction: None or describe. Monitoring period: Monitoring period Final status: Stable/status. Patient instructions: Instructions reviewed. Complications: None or describe.
What documentation is required for D9612?
D9612 is graded line-by-line — auditors confirm that each drug has a complete chain. A defensible note includes:
- Reviewed medical history with date — confirm allergies, current medications, pregnancy status if applicable, renal/hepatic concerns, and any drug-interaction screen relevant to today's medications
- Allergy verification — explicit "NKDA" or list. Do not skip this even when restated from intake
- Weight (kg) — required for any weight-based dosing (most steroids, antibiotics in pediatrics, ketorolac in select populations) and a defensible chart entry even when not weight-based
- Indication / diagnosis for each drug — name the clinical reason: "surgical site infection prophylaxis," "post-op edema control," "post-op nausea prophylaxis," "acute allergic reaction." A drug administered without a charted indication is a top denial reason
- Related procedure(s) — what surgical or therapeutic encounter the medication supports (e.g., "D7240 #32 impaction, IV moderate sedation D9239")
- Per-administration block — repeat for every drug:
- Drug name (generic preferred, brand if patient-specific)
- Dose with units (mg, mcg, mL, units)
- Route (IM / IV / SubQ / submucosal / intraosseous / intranasal)
- Site (e.g., "right deltoid IM," "left antecubital IV," "buccal vestibule submucosal #19 area")
- Time of administration (clock time, not "during procedure")
- Lot number and expiration date of the vial/ampule used — required for FDA-traceable medications and a near-universal Medicaid audit element
- Operator initials — who actually pushed/injected the drug
- Pre- and post-administration vitals — BP, HR, SpO2, and respiratory rate when sedation-adjacent. Vitals at minimum at baseline and after each drug class (a single set "after everything" weakens the chain when one drug is later questioned)
- Patient response — therapeutic response (pain reduction, nausea relief, allergic-reaction resolution) and any adverse reaction. "No adverse reaction" is acceptable when true; "patient tolerated well" alone is not specific enough to defend against an audit
- Monitoring period and final status — duration of in-office observation after the last drug and the patient's status at discharge (stable, ambulatory, escorted)
- Patient instructions / discharge — what the patient was told, including signs to watch for, when to contact the office, and any home medication plan
- Complications — "none" is acceptable; describe in detail if any
- Provider signature and assistant/operator initials
The single most common audit failure on D9612 is a note that proves one drug was administered but not clearly the second — the code requires explicit documentation of each distinct medication, each with its own complete administration record. Default-normal autotext that lists drugs in a single line ("Cefazolin 1 g and Dexamethasone 8 mg given IM") will be down-coded to D9610 by carriers that audit.
Why does D9612 get denied?
The most common reasons D9612 is denied, downgraded, or audited:
- Drugs are part of the sedation plan — bundled into D9222/D9223/D9239/D9243 because the agents reported (e.g., midazolam + fentanyl, propofol + lidocaine) are integral to the sedation itself, not separate therapeutic medications
- Only one drug actually documented — the chart proves a single administration; the "two or more" requirement fails and the carrier down-codes to D9610 or denies entirely
- Same drug administered twice — two doses of the same medication (e.g., dexamethasone given pre- and post-op) is not D9612; it is D9610 once. D9612 specifically requires different medications
- Missing lot number / expiration — Medicaid MCOs and many commercial carriers explicitly require this on parenteral drug claims; absence is an automatic denial trigger on audit
- Missing site/route/time — even one missing element on one administration causes the line to fail
- No charted indication — drug given without a stated therapeutic reason; "patient comfort" alone does not satisfy
- Local anesthetic counted as a drug — D9215 cannot be one of the two; reporting local + steroid as "two drugs" under D9612 is a known miscoding pattern
- N2O counted as a drug — D9230 (nitrous) is also excluded; N2O + IM antibiotic is not D9612
- Oral medications counted — pre-op oral antibiotic + IM steroid is not D9612; the code requires parenteral (non-enteral) administration for all counted drugs
- Reporting D9610 and D9612 same DOS — mutually exclusive; carrier will pay one and deny the other
- Reported without a related procedure — billed in isolation with no surgical/endodontic/emergency context, the medical necessity is unclear and carriers flag for review
- Provider not credentialed for the route — IV administration billed by a provider whose state license does not permit IV therapy is a state-board issue beyond the carrier denial
- Duplicate billing across dental and medical claims — drugs paid on a hospital/facility claim resubmitted on dental ledger
What do practices ask about D9612?
What's the difference between D9610 and D9612?+
D9610 reports a single parenteral therapeutic drug administered in office; D9612 reports two or more different parenteral therapeutic drugs on the same date of service. The distinction is the number of distinct medications, not the number of injections. One drug given in three sites is D9610. Two different drugs (e.g., an antibiotic plus a steroid) given once each is D9612.
Can I bill D9612 multiple times if I administered three or four different drugs?+
No. D9612 is reported once per date of service regardless of whether two, three, or five different drugs were administered. The code's 'two or more' is satisfied by a single line. Document each drug's administration completely in the chart, but bill the code only once.
Can I bill D9612 alongside IV moderate sedation (D9239)?+
Yes, but only when the drugs reported under D9612 are clearly separate from the sedation plan. The midazolam, fentanyl, propofol, or ketamine that defines the sedation case is already inherent to D9239/D9243 and cannot be re-reported under D9612. A perioperative IM antibiotic plus an IM corticosteroid given for distinct therapeutic indications is reportable; the sedation cocktail itself is not.
Does local anesthetic count as one of the two drugs under D9612?+
No. D9215 (local anesthesia) is excluded by the ADA descriptor for D9612. Local anesthetic is its own separately reported service when payable, and combining it with a single therapeutic drug under D9612 to satisfy the 'two or more' is a known miscoding pattern that carriers downcode to D9610 on audit.
What documentation does a defensible D9612 chart entry require?+
Each drug needs its own complete administration block: drug name, dose, route, site, time, lot number, expiration, and the operator's initials — plus a clear therapeutic indication for each medication and pre/post vitals. The single most common D9612 audit failure is a note that proves one drug was given but not clearly the second.
Can I bill D9612 if the patient received an oral pre-medication plus an IM injection?+
No. D9612 requires that all counted drugs be administered parenterally — non-enteral routes such as IM, IV, SubQ, submucosal, intraosseous, or intranasal. An oral pre-medication does not count toward the 'two or more' requirement. If the only parenteral drug administered was the IM injection, that is D9610.
Is D9612 typically a high-dollar reimbursement?+
No. Many carriers reimburse D9612 modestly or bundle it into the related surgical or sedation code. The primary reason to code it correctly is documentation completeness — for medication-error and adverse-event traceability, lot/expiration audit defense, and clean coordination with the related procedural codes — not revenue.